BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26291661)

  • 1. Why are second-generation H1-antihistamines minimally sedating?
    Hu Y; Sieck DE; Hsu WH
    Eur J Pharmacol; 2015 Oct; 765():100-6. PubMed ID: 26291661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacology of non-sedating antihistamines.
    Yanai K; Yoshikawa T; Yanai A; Nakamura T; Iida T; Leurs R; Tashiro M
    Pharmacol Ther; 2017 Oct; 178():148-156. PubMed ID: 28457804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists.
    Uesawa Y; Hishinuma S; Shoji M
    J Pharmacol Sci; 2014; 124(2):160-8. PubMed ID: 24476926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
    Chen C; Hanson E; Watson JW; Lee JS
    Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
    Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
    Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis.
    Bender BG; Berning S; Dudden R; Milgrom H; Tran ZV
    J Allergy Clin Immunol; 2003 Apr; 111(4):770-6. PubMed ID: 12704356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antihistamines: a critical view.
    Camelo-Nunes IC
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S173-80. PubMed ID: 17136293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
    Kavosh ER; Khan DA
    Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
    Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine.
    Polli JW; Baughman TM; Humphreys JE; Jordan KH; Mote AL; Salisbury JA; Tippin TK; Serabjit-Singh CJ
    J Pharm Sci; 2003 Oct; 92(10):2082-9. PubMed ID: 14502547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines.
    Chishty M; Reichel A; Siva J; Abbott NJ; Begley DJ
    J Drug Target; 2001 Jun; 9(3):223-8. PubMed ID: 11697207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihistamines in dermatology.
    Greaves MW
    Skin Pharmacol Physiol; 2005; 18(5):220-9. PubMed ID: 16015020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
    Belsito DV
    J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
    Zuberbier T
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsedating H1 antihistamines in chronic urticaria.
    Monroe EW
    Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
    Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
    Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.
    Montoro J; Bartra J; Sastre J; Dávila I; Ferrer M; Mullol J; del Cuvillo A; Jáuregui I; Valero A
    J Investig Allergol Clin Immunol; 2013; 23 Suppl 1():17-26. PubMed ID: 24672891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A potential of positron emission tomography in the drug development of non-sedative antihistamines].
    Tashiro M; Yanai K
    Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():78P-80P. PubMed ID: 14727529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.